Tumor-Induced Osteomalacia: Treatment Progress Using Burosumab, an Anti-FGF23 Monoclonal Antibody

Research output: Contribution to journalEditorial

Original languageEnglish
Pages (from-to)625-626
Number of pages2
JournalJournal of Bone and Mineral Research
Volume36
Issue number4
DOIs
StatePublished - Apr 2021

Cite this